177
Views
11
CrossRef citations to date
0
Altmetric
Review

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria

, , &
Pages 197-205 | Published online: 03 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Abdullah Baharudin, Amir Hamzah Abdul Latiff, Kent Woo, Felix Boon-Bin Yap, Ing Ping Tang, Kin Fon Leong, Wai Seong Chin & De Yun Wang. (2019) Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations. Therapeutics and Clinical Risk Management 15, pages 1267-1275.
Read now
Rosa Antonijoan, Jimena Coimbra, Consuelo García-Gea, Montserrat Puntes, Ignasi Gich, Cristina Campo, Román Valiente & Luis Labeaga. (2017) Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers. Current Medical Research and Opinion 33:1, pages 129-136.
Read now

Articles from other publishers (9)

Aliaa M. Abdelshafy, Sara Y. Abdallah, Ahmed F. Hassan, Hazem A. Mohamed, Nourhan M. Kamal, Sohila T. Ali & Ibrahim A. Abdelhaleem. (2022) The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Rhinology & Allergy 36:5, pages 684-694.
Crossref
Chaejin Kim, Valentina Lo Re, Monica Rodriguez, John C. Lukas, Nerea Leal, Cristina Campo, Aintzane García‐Bea, Elena Suarez, Stephan Schmidt & Valvanera Vozmediano. (2021) Application of a dual mechanistic approach to support bilastine dose selection for older adults. CPT: Pharmacometrics & Systems Pharmacology 10:9, pages 1006-1017.
Crossref
Dolores Ochoa, Manuel Román, Carmen Belmonte, Samuel Martín-Vilchez, Gina Mejía-Abril, Francisco Abad-Santos, Gonzalo Hernández, Paula Arranz, Lorena Elgezabal & Nieves Fernández. (2021) Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation. Advances in Therapy 38:7, pages 4070-4081.
Crossref
Mónica Rodríguez, Valvanera Vozmediano, Aintzane García-Bea, Zoltán Novák, Anahí Yáñez, Cristina Campo & Luis Labeaga. (2020) Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria. European Journal of Pediatrics 179:5, pages 801-805.
Crossref
K. Sugita & O. Yamamoto. (2018) Hypereosinophilia successfully treated with the novel antihistamine bilastine. Clinical and Experimental Dermatology 44:5, pages 586-588.
Crossref
Valvanera Vozmediano, John C. Lukas, Esther Encinas, Stephan Schmidt, Ander Sologuren, Román Valiente, Luis Labeaga, Cristina Campo & Mónica Rodriguez. (2019) Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population. European Journal of Pharmaceutical Sciences 128, pages 180-192.
Crossref
Valvanera Vozmediano, Ander Sologuren, John C. Lukas, Nerea Leal & Mónica Rodriguez. (2017) Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study Design. Pharmaceutical Research 34:12, pages 2720-2734.
Crossref
Irini Akritopoulou-Zanze. 2016. Bioactive Carboxylic Compound Classes: Pharmaceuticals and Agrochemicals. Bioactive Carboxylic Compound Classes: Pharmaceuticals and Agrochemicals 237 244 .
Erminia Ridolo, Marcello Montagni, Laura Bonzano, Cristoforo Incorvaia & Giorgio Walter Canonica. (2015) Bilastine: new insight into antihistamine treatment. Clinical and Molecular Allergy 13:1.
Crossref